Ionis Pharmaceuticals - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeIonis Pharmaceuticals
Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

0 followers

IONS

Performance

About Ionis Pharmaceuticals

Ionis Pharmaceuticals is a biopharmaceutical company focused on discovering and delivering RNA- and DNA-targeted medicines to address serious diseases. Through antisense chemistry and innovative genetic therapies, the company pursues treatments across neurology, cardiometabolic disorders, and select rare diseases, aiming to improve patient outcomes globally. Headquartered in Carlsbad, California, Ionis combines scientific expertise with a deep pipeline to advance next-generation therapies from research to clinical development.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Brett P. Monia, Ph.D.

Chief Executive Officer

Brian Birchler

Executive Vice President, Corporate and Development Operations

C. Frank Bennett, Ph.D.

Executive Vice President, Chief Scientific Officer

Elizabeth L. Hougen

Executive Vice President, Chief Financial Officer

Key Facts

HQ Location

Carlsbad, United States

Founded

1989

Employees

1K-5K

Status

Public

Website

https://ionis.com